OncoGenex Pharmaceuticals (OGXI) Commences Common Stock Offering
Tweet
Share
E-mailGet Alerts OGXI Hot Sheet
Join SI Premium – FREE
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) has commenced a public offering of its common stock. OncoGenex expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in the public offering to cover overallotments, if any.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BKV registers 5.3 million shares for resale tied to power JV deal
- Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
- Entera Bio Ltd. (ENTX) files for 134.8M share offering by selling stockholders
Create E-mail Alert Related Categories
Equity OfferingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
